Boulding Mark Elliott sold PTCT
January 9, 2026 · Form 4 insider transaction
Boulding Mark Elliott sold 686 shares of PTC Therapeutics, Inc. at $78.71 per share, a transaction worth $54.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.; This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.23 to $79.21 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.